Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 42OTHER_GOV 3NIH 1INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 2Neoplasms 1Hemangioma, Capillary 1Disease 1Cerebral Hemorrhage 1Arteriovenous Malformations 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Ultrasonography × Clear all
NCT02656407 2025-09-02

FUSIMAGINE

Institut National de la Santé Et de la Recherche Médicale, France

Phase NA Completed
23 enrolled
CNS

Brain Neoplasms

NCT05484245 2025-05-16

SOMALI

Sklifosovsky Institute of Emergency Care

Phase NA Recruiting
100 enrolled
CNS

Arteriovenous Malformations, Brain Neoplasms, Cerebral Hemorrhage, Hemangioma, Capillary

NCT05927727 2023-07-03

Benign-Malign Differentiation of Axillary Lymph Nodes: The Role Of Superb Microvascular Imaging

Ankara Education and Research Hospital

Phase NA Completed
102 enrolled

Disease, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡